granular corneal dystrophy

granular corneal dystrophy

an autosomal dominant disorder characterized by hyaline deposits in the corneal stroma.

gran·u·lar cor·ne·al dys·tro·phy

(gran'yū-lăr kōr'nē-ăl dis'trŏ-fē)
An autosomal dominant disorder characterized by hyaline deposits in the corneal stroma
References in periodicals archive ?
About Avellino Labs Avellino Labs has developed the first and only commercially available testing system, the DNA Test for LASIK and Refractive Surgery Safety, for Granular Corneal Dystrophy type 1 (GCD1) and Granular Corneal Dystrophy type 2 (GCD2), also known as Avellino Corneal Dystrophy (ACD).
RBCD is also known as corneal dystrophy of Bowman layer type I and granular corneal dystrophy type 3.
Genetic Test for Refractive Surgery Safety has Screened Nearly a half-million Patients for Granular Corneal Dystrophy with 450 Positive Results
April 15, 2015 /PRNewswire/ -- Avellino Lab USA, developer of the first genetic test for Granular Corneal Dystrophy (GCD), today announced that Peter Falzon has joined the company as Chief Executive Officer.
The Avellino DNA Dual Test was developed to detect Granular Corneal Dystrophy type 1 (GCD1) and type 2 (GCD2), a disease that causes cloudiness, specifically grey-white granular protein deposits on the corneas, which can lead to loss of clear vision.
About Avellino Lab USA Avellino Lab USA has developed the first and only commercially available testing system, the Avellino DNA Dual Test for LASIK Safety, for Granular Corneal Dystrophy type 1 (GCD1) and Granular Corneal Dystrophy type 2 (GCD2), also known as Avellino Corneal Dystrophy (ACD).
April 24, 2014 /PRNewswire/ -- Avellino Lab USA, developer of the Avellino-GENE Detection System (AGDS(TM)) Test, the first genetic test for Avellino Corneal Dystrophy (ACD), will introduce the Avellino DNA Dual Test for LASIK Safety, a genetic test that can detect for both ACD and another genetic mutation, Granular Corneal Dystrophy type I (GCD1), at the American Society of Cataract and Refractive Surgery Annual Symposium (ASCRS) in Boston, Massachusetts at booth #266.
Avellino Lab USA has developed the first and only commercially available testing system for Avellino Corneal Dystrophy (ACD), also known as Granular Corneal Dystrophy type 2.
About Avellino Lab USA Avellino Lab USA has developed the first and only commercially available testing system for Avellino Corneal Dystrophy (ACD), also known as Granular Corneal Dystrophy type 2.